+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Inside a biotech VC's anger-driven strategy

Oct 13, 2021, 19:13 IST
Business Insider
Kristina Burow, managing director at Arch Venture Partners. Arch Venture Partners

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...

A top biotech VC looks for 2 factors when investing in startups that could shake up the healthcare industry

Get an inside look>>

Alloy cofounder and CEO Anne Fulenwider Sharon Suh/Courtesy of Alloy
Here is the 23-slide presentation a former Marie Claire editor-in-chief used to get millennial men to invest in a startup that treats menopause symptoms

See the slides now>>

Advertisement

A pharmacist administers the AstraZeneca COVID-19 vaccine to a patient in a pharmacy in Roubaix as part of the coronavirus disease (COVID-19) vaccination campaign in France, March 15, 2021. REUTERS/Pascal Rossignol
Vaccines cut the risk of severe COVID-19 by at least 90% in a huge real-world study of 23 million people

Check it out>>

More stories we're reading:

-Leah

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article